Trial intelligence / Profile preview

Ropivacaine concentration comparison for interscalene brachial plexus block combined with general anesthesia in arthroscopic shoulder surgery

ChiCTR2000035647Phase 4Not yet recruiting

Sponsor
Sichuan Provincial People's Hospital
Start
Sep 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of ropivacaine in postoperative pain and Shoulder disorder (3 arms), sponsored by Sichuan Provincial People's Hospital. Primary endpoints: systolic blood pressure, diastolic blood pressure and 3 more. Planned start Sep 2020; status: not yet recruiting.

02

Drugs

ropivacaine
03

Conditions

postoperative painShoulder disorder

Beyond the preview

Go deeper on ChiCTR2000035647.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000035647.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call